Showing 791-800 of 4112 results for "".
The Value of Current and Past Patients
https://practicaldermatology.com/topics/practice-management/the-value-of-current-and-past-patients/20986/Seven ways to maximize patient engagement opportunities.Marathon Dermatology
https://practicaldermatology.com/topics/general-topics/marathon-dermatology/20997/As the popularity of running continues to grow, dermatologists need rapid ready responses to address acute presenting problems, as well as counseling measures to help prevent recurrence.The Benjamin Button Effect: Noninvasive Rejuvenation
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/the-benjamin-button-effect-noninvasive-rejuvenation/18813/Heidi Waldorf, MD explains her approach to helping patients achieve the best, most natural results from noninvasive rejuvenation. She says her patients want to look like themselves after aesthetic treatment—but a healthier, more youthful version of themselves. Dr. Waldorf shares tips for interactingChemoprevention Strategies for AK Patients
https://practicaldermatology.com/topics/skin-cancer-photoprotection/chemoprevention-strategies-for-ak-patients/18822/Neal Bhatia, MD, Chief Medical Editor of Practical Dermatology®, provides strategies for treating actinic keratoses, as well as for prevention and management. He discusses the importance of sun protection and photodamage prevention, and says the key to treatment and maintenance is combination therapCosmeceutical Advances in 2016
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/cosmeceutical-advances-in-2016/18622/Suneel Chilukuri, MD discusses recent advances in the cosmeceutical market including a new topical formulated to protect the skin from UVA/UVB damage as well as from infrared radiation, a skin brightening topical formulated to carry retinol deeper into the skin, and a topical hyaluronic acid productPearls for Injectables: From Toxins to Fillers
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/pearls-for-injectables-from-toxins-to-fillers/18628/Ava Shamban, MD shares her rationale for thinking of the face in three treatment areas for rejuvenation procedures—upper, middle, and lower. Devising strategies with injections targeted to each area will help patients achieve more natural recountouring while achieving the youthful appearance they deThe Rising Costs of Prescription Drugs
https://practicaldermatology.com/topics/practice-management/the-rising-costs-or-prescription-drugs/18677/What's really causing the costs of dermatology prescriptions, especially generics, to skyrocket? Jake Levitt, MD and Mark Lebwohl, MD speak to host Neal Bhatia, MD about what's influencing these rising costs, and who, if anyone, is benefiting. Dr. Levitt talks about the rebate system between manufacPruritus: A Marker For Cancer?
https://practicaldermatology.com/topics/practice-management/pruritus-a-marker-for-cancer/21181/Though the relationship is well known, new studies validate concerns regarding the link between pruritus and malignancy.Ask An Expert: Establishing Yourself as an Expert
https://practicaldermatology.com/topics/practice-management/ask-an-expert-establishing-yourself-as-an-expert/18937/In this edition of NewDermMD's video series, host Adam Friedman, MD speaks with Neal Bhatia, MD about establishing one's expertise, becoming an educator, and finding a comfortable place working with industry, peers, and societies. Whether your interest is in cosmetic dermatology, acne, psoriasis, peOtezla Approved for Plaque Psoriasis
https://practicaldermatology.com/topics/psoriasis/dermiretv-otezla-approved-for-plaque-psoriasis/19031/In this week's edition of DermWireTV from the publishers of Practical Dermatology® magazine and DermWire.com, a look at Celgene's Otezla for psoriasis--the first PDE4 inhibitor approved for plaque psoriasis. Plus, Ranbaxy's new dosage strengths of Absorica (isotretinoin), and Galderma's search for p